In a recent study, it had been examined whether increased levels of expression of CD133 mRNA by semi-quantitative real-time RT-PCR analysis in peripheral blood predicted disease recurrence in patients with colon cancer. This evidence concerns the gene PROM1 and malignant colon neoplasm.